Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT05747794

Active, not recruiting

Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination with Paclitaxel Chemotherapy (AIPAC-003)

Breast Carcinoma
NCT06344780

Active, not recruiting

Abemaciclib, Palbociclib or Dalpiciclib Combined with Endocrine Therapy As First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer

Breast Cancer
NCT01186367

Completed

Trial Comparing the Effects of Linear Versus Nonlinear Aerobic Training in Women With Operable Breast Cancer (Excite)

Breast Cancer
NCT06172270

Completed

Sub-regional Tumor Segmentation Based on CEUS Perfusion Characteristics: Enhancing Breast Tumor Diagnosis

Breast Tumor
NCT03944434

Active, not recruiting

FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer (FACILE)

Breast Cancer
NCT06881550

Enrolling by invitation

Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer Surgery

Breast Cancer
NCT01781338

Completed

Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer (ADAPT)

Breast Cancer
NCT06793306

Enrolling by invitation

A Study Comparing the Differences Between Young and Non-young Breast Cancer

Breast Cancer
NCT05173415

Completed

Marker Technique Comparison in Targeted Axillary Dissection (MALLORCA)

Breast Cancer
NCT06347393

Active, not recruiting

Transgender and Gender Diverse Individuals Screening for Breast Cancer (GENESIS)

Breast Cancer
NCT00971087

Completed

Multicenter Hologic Tomosynthesis Study

Breast Cancer
NCT02547987

Active, not recruiting

Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer (CADENCE)

Breast Cancer
NCT05395871

Completed

Behavioural Science Messages in Breast Cancer Screening

Breast Cancer
NCT01937052

Completed

Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database

Breast Cancer
NCT03795493

Completed

Diet Restriction and Exercise-induced Adaptations in Metastatic Breast Cancer (DREAM)

Breast Cancer
NCT05293964

Active, not recruiting

Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer

Breast Cancer
NCT04657679

Terminated

Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts (LEANORA)

Breast Cancer
NCT02339532

Completed

Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status (NeoTOP)

Breast Cancer
NCT04060862

Terminated

A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer (IPATunity150)

Breast Cancer
NCT03615573

Completed

Survey Study: Financial Impact of Breast Cancer Treatment

Breast Cancer
NCT02229084

Completed

Vaccination of High Risk Breast Cancer Patients

Breast Cancer | Breast Neoplasms
NCT04083027

Completed

Non-mass Enhancement in Breast MRI

Breast Neoplasm
NCT01189851

Completed

Intraoperative Radiotherapy for Early Stage Breast Cancer (IORT)

Breast Cancer
NCT06637150

Active, not recruiting

Dalpicilib-Enhanced Vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer

Breast Cancer
NCT06635239

Completed

Massive Open Online Course (MOOC) for Women with Breast Cancer

Breast Cancer
NCT03839823

Completed

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer (RIGHT Choice)

Breast Cancer
NCT05978960

Completed

EXERT-BCN: an Exercise and Nutrition Regimen to Designed to Improve Body Composition After Treatment for Breast Cancer (EXERT-BCN)

Breast Cancer
NCT05966584

Terminated

A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

Breast Cancer
NCT01414062

Completed

Cook for Your Life!: Implementing Dietary Change Among Hispanic Breast Cancer Survivors

Breast Cancer
NCT03956654

Completed

A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer (RibOB)

Breast Cancer
NCT06546072

Completed

Deep Learning With MRI-based Multimodal-data Fusion Enhanced Postoperative Risk Stratification of Breast Cancer

Breast Cancer
NCT04909554

Completed

MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Therapy in Breast Cancer (NeoMDSS)

Breast Cancer
NCT06510127

Enrolling by invitation

An AI Model Predicts the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: a Multicenter, Bidirectional Cohort Study

Breast Cancer
NCT03930797

Completed

Coping Together After Breast Cancer

Breast Cancer
NCT03514433

Completed

Translating Research Into Practice: Patient Navigation for Breast Cancer (TRIP)

Cancer, Breast
NCT03393741

Terminated

Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy

Breast Cancer | Breast Neoplasms
NCT06469684

Completed

A Health Education Intervention Tailored for Malay-Muslim Women

Breast Cancer
NCT05731453

Active, not recruiting

Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening

Breast Cancer
NCT02407613

Withdrawn

Efficacy of MR-HIFU Ablation of Breast Cancer

Breast Cancer
NCT04594473

Completed

A Comprehensive Oncology Rehabilitation and Exercise (CORE) Program Among Breast Cancer Survivors (CORE)

Breast Cancer
NCT01064635

Active, not recruiting

Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4) (GIM4)

Breast Cancer
NCT02850939

Completed

Improving Adherence to EHT Among Breast Cancer Patients

Breast Cancer
NCT04129216

Completed

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer

Breast Cancer
NCT03982485

Active, not recruiting

Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer (APP)

Breast Cancer
NCT05629949

Completed

A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Plus Docetaxel Versus Herceptin® Plus Docetaxel as First Line Therapy in Patients With HER2-positive Metastatic Breast Cancer

Breast Cancer
NCT01834521

Completed

Web-based Screening and Tailored Support (ENCOURAGE)

Breast Cancer
NCT04629846

Completed

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.

Breast Cancer
NCT03770598

Completed

Team Based Psychosocial Care to Promote, Maintain and Restore Wellness of Breast Cancer Patients

Breast Cancer
NCT06373744

Completed

Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients

Breast Cancer
NCT02453737

Completed

A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast Ca

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations